Abbott Laboratories - Exact Sciences
MN-95002
View on ACCC websiteStage
Phase 1 - initial assessment
Effective Notification
02/02/2026
End of Determination Period
17/03/2026
Determination Published
24/02/2026 (22 cal / 16 bus. days)
Determination
Acquirers
Badger Merger Sub I, Inc
10389384
Targets
Exact Sciences Corporation
020478229
Description
Abbott Laboratories (Abbott), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation (Exact Sciences) through an Agreement and Plan of Merger.
Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.
Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing.
The parties both supply oncological diagnostic products in Australia.
Industries
Timeline & Events
-
-
-
Merger notified to ACCC
02/02/2026